No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
Advaxis and Ayala Pharmaceuticals Complete Merger
Advaxis, Inc. (OTCMKTS:ADXS) Sees Significant Decline in Short Interest
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Advaxis, Inc. (ADXS)
Short Interest in Advaxis, Inc. (OTCMKTS:ADXS) Drops By 27.5%
Advaxis, Inc. (OTCMKTS:ADXS) Short Interest Down 27.5% in September
Advaxis Reports Third Quarter Ended July 31, 2022 Financial Results and Provides a Business Update
No Data